MedPath

A randomized study comparing Esomeprazole based versus rabeprazole based triple therapy for the eradication of Helicobacter pylori.

Not Applicable
Conditions
Helicobacter pylori infection
Registration Number
JPRN-UMIN000007550
Lead Sponsor
Oita University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
220
Inclusion Criteria

Not provided

Exclusion Criteria

Past history of allergy for the drugs used in this study. Past history of taking eradication therapy. Past history of gastrectomy. Gastric cancer patients, pregnancy or lactation . Severe renal dysfunction ,Blood disease, Infectious Mononucleosis Patients who are disqualified for the study by their physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath